Research on the regulation of electronic prescription circulation under the mode of “medical science + pharmacy”
- VernacularTitle:“医+药”模式下的电子处方流转监管研究
- Author:
Mengdie LI
1
;
Rongli SHI
1
;
Kai SHEN
1
;
Guiping WU
1
Author Information
1. School of Pharmaceutical Business，Guangdong Pharmaceutical University/Guangdong Research Base for Drug Regulatory Science/Key Laboratory of Pharmacovigilance Technology Research and Evaluation of National Medical Products Administration，Guangzhou 510006，China
- Publication Type:Journal Article
- Keywords:
electronic prescription circulation;
evolutionary game;
prescription regulation;
internet hospital;
third-party drug
- From:
China Pharmacy
2023;34(14):1665-1670
- CountryChina
- Language:Chinese
-
Abstract:
OBJECTIVE To provide reference for the regulation of electronic prescription circulation under the mode of “medical science + pharmacy”. METHODS Based on evolutionary game theory， a tripartite evolutionary game model was constructed for related parties of electronic prescription circulation （government agencies， internet hospitals and third-party drug platforms） under the mode of “medical science + pharmacy”. The influential factors of the three parties’ strategy selection were analyzed and verified by simulation. RESULTS & CONCLUSIONS The strategic choices of all parties in the game were affected by the other two parties. Reducing the cost of strict supervision or increasing the punishment for the other two parties would increase the probability of strict supervision of government agencies. Enhancing reputation losses， increasing penalties， and reducing the cost difference when choosing different strategies would have regulatory and binding effects on internet hospitals and third-party drug platforms. It is suggested that government agencies can introduce diversified supervision mode and establish an integrated “intelligent supervision + traceability” system； pay attention to the construction of reputation mechanism， and promote the coordinated linkage of all parties； increase the punishment for violations， provide policy support， reduce the cost of compliance behavior to promote the high-quality development of electronic prescription circulation under the mode of “medical science + pharmacy”.
